Oct 03, 2011, 03.56 PM IST | Source: Moneycontrol.com

Vivimed Labs acquires privately held Klar Sehen

Vivimed Labs has acquired entire equity stake in Kolkata-based privately held pharma company Klar Sehen to boost its domestic presence specialty medicine areas.

Vivimed Labs acquires privately held Klar Sehen
Moneycontrol Bureau

Vivimed Labs has acquired entire equity stake in Kolkata-based privately held pharma company Klar Sehen to boost its domestic presence in specialty medicine areas.

The financial terms of the deal were not disclosed.

The 30-year-old company operates in a niche ophthalmic segment and owns about 50 trademarks and brands like Renicol, Dexacort, Lysicon-V,  in eye care, Vivimed said Monday.

Klar Sehen has strong marketing presence in North East, Bihar and Andhra Pradesh, it said. It has manufacturing facilities at Kolkata and Hyderabad and also has arrangements to manufacture some of its products in Uttarakhand, and operates with over 150 medical sales professionals, Vivimed said.

Earlier last month Vivimed had completed the acquisition of Octtantis Nobel, a Hyderabad-based pharmaceutical marketing company.

Vivimed Labs shares were trading up 1.2% at Rs 247.50 on NSE on Monday.

Vivimed Labs stock price

On April 17, 2014, Vivimed Labs closed at Rs 229.90, up Rs 1.55, or 0.68 percent. The 52-week high of the share was Rs 309.85 and the 52-week low was Rs 96.00.


The company's trailing 12-month (TTM) EPS was at Rs 19.14 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 12.01. The latest book value of the company is Rs 212.43 per share. At current value, the price-to-book value of the company is 1.08.

Set email alert for

ADS BY GOOGLE

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Narendra Modi

83625.93 1,390.04 1.69%

5486

Bought today

4551

Sold today

2.02%

User holding

video of the day

Chandra says satisfied with TCS' FY14, FY15 to be better

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.